Literature DB >> 17962410

Human G(salpha) mutant causes pseudohypoparathyroidism type Ia/neonatal diarrhea, a potential cell-specific role of the palmitoylation cycle.

Noriko Makita1, Junichiro Sato, Philippe Rondard, Hiroshi Fukamachi, Yasuhito Yuasa, Micheala A Aldred, Makiko Hashimoto, Toshiro Fujita, Taroh Iiri.   

Abstract

Pseudohypoparathyroidism type Ia (PHP-Ia) results from the loss of one allele of G(salpha), causing resistance to parathyroid hormone and other hormones that transduce signals via G(s). Most G(salpha)mutations cause the complete loss of protein expression, but some cause loss of function only, and these have provided valuable insights into the normal function of G proteins. Here we have analyzed a mutant G(salpha) (alphas-AVDT) harboring AVDT amino acid repeats within its GDP/GTP binding site, which was identified in unique patients with PHP-Ia accompanied by neonatal diarrhea. Biochemical and intact cell analyses showed that alphas-AVDT is unstable but constitutively active as a result of rapid GDP release and reduced GTP hydrolysis. This instability underlies the PHP-Ia phenotype. alphas-AVDT is predominantly localized in the cytosol, but in rat and mouse small intestine epithelial cells (IEC-6 and DIF-12 cells) alphas-AVDT was found to be localized predominantly in the membrane where adenylyl cyclase is present and constitutive increases in cAMP accumulation occur in parallel. The likely cause of this membrane localization is the inhibition of an activation-dependent decrease in alphas palmitoylation. Upon the overexpression of acyl-protein thioesterase 1, however, alphas-AVDT translocates from the membrane to the cytosol, and the constitutive accumulation of cAMP becomes attenuated. These results suggest that PHP-Ia results from the instability of alphas-AVDT and that the accompanying neonatal diarrhea may result from its enhanced constitutive activity in the intestine. Hence, palmitoylation may control the activity and localization of G(salpha) in a cell-specific manner.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17962410      PMCID: PMC2077272          DOI: 10.1073/pnas.0708561104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Germline mosaicism for a GNAS1 mutation and Albright hereditary osteodystrophy.

Authors:  M A Aldred; R J Bagshaw; K Macdermot; D Casson; S H Murch; J A Walker-Smith; R C Trembath
Journal:  J Med Genet       Date:  2000-11       Impact factor: 6.318

Review 2.  Assembly and trafficking of heterotrimeric G proteins.

Authors:  Yannick Marrari; Marykate Crouthamel; Roshanak Irannejad; Philip B Wedegaertner
Journal:  Biochemistry       Date:  2007-06-09       Impact factor: 3.162

3.  An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations.

Authors:  Noriko Makita; Junichiro Sato; Katsunori Manaka; Yuki Shoji; Atsuro Oishi; Makiko Hashimoto; Toshiro Fujita; Taroh Iiri
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-19       Impact factor: 11.205

Review 4.  Mechanisms of disease: Mutations of G proteins and G-protein-coupled receptors in endocrine diseases.

Authors:  Andrea G Lania; Giovanna Mantovani; Anna Spada
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2006-12

Review 5.  Palmitoylation: policing protein stability and traffic.

Authors:  Maurine E Linder; Robert J Deschenes
Journal:  Nat Rev Mol Cell Biol       Date:  2007-01       Impact factor: 94.444

6.  Chemotactic peptide receptor-supported ADP-ribosylation of a pertussis toxin substrate GTP-binding protein by cholera toxin in neutrophil-type HL-60 cells.

Authors:  T Iiri; M Tohkin; N Morishima; Y Ohoka; M Ui; T Katada
Journal:  J Biol Chem       Date:  1989-12-15       Impact factor: 5.157

7.  Palmitoylation is required for signaling functions and membrane attachment of Gq alpha and Gs alpha.

Authors:  P B Wedegaertner; D H Chu; P T Wilson; M J Levis; H R Bourne
Journal:  J Biol Chem       Date:  1993-11-25       Impact factor: 5.157

8.  Reconstitution of agonist-stimulated phosphatidylinositol 4,5-bisphosphate hydrolysis using purified m1 muscarinic receptor, Gq/11, and phospholipase C-beta 1.

Authors:  G Berstein; J L Blank; A V Smrcka; T Higashijima; P C Sternweis; J H Exton; E M Ross
Journal:  J Biol Chem       Date:  1992-04-25       Impact factor: 5.157

9.  Modification of the function of pertussis toxin substrate GTP-binding protein by cholera toxin-catalyzed ADP-ribosylation.

Authors:  T Iiri; Y Ohoka; M Ui; T Katada
Journal:  J Biol Chem       Date:  1992-01-15       Impact factor: 5.157

10.  Activation of the alpha subunit of Gs in intact cells alters its abundance, rate of degradation, and membrane avidity.

Authors:  M J Levis; H R Bourne
Journal:  J Cell Biol       Date:  1992-12       Impact factor: 10.539

View more
  10 in total

1.  V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists.

Authors:  Kazuhiro Takahashi; Noriko Makita; Katsunori Manaka; Masataka Hisano; Yuko Akioka; Kenichiro Miura; Noriyuki Takubo; Atsuko Iida; Norishi Ueda; Makiko Hashimoto; Toshiro Fujita; Takashi Igarashi; Takashi Sekine; Taroh Iiri
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

2.  Regulation of RhoA signaling by the cAMP-dependent phosphorylation of RhoGDIα.

Authors:  Atsuro Oishi; Noriko Makita; Junichiro Sato; Taroh Iiri
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

Review 3.  GNAS Spectrum of Disorders.

Authors:  Serap Turan; Murat Bastepe
Journal:  Curr Osteoporos Rep       Date:  2015-06       Impact factor: 5.096

4.  Molecular basis of a novel oncogenic mutation in GNAO1.

Authors:  M Garcia-Marcos; P Ghosh; M G Farquhar
Journal:  Oncogene       Date:  2011-02-14       Impact factor: 9.867

5.  Cinacalcet corrects biased allosteric modulation of CaSR by AHH autoantibody.

Authors:  Noriko Makita; Takao Ando; Junichiro Sato; Katsunori Manaka; Koji Mitani; Yasuko Kikuchi; Takayoshi Niwa; Masanori Ootaki; Yuko Takeba; Naoki Matsumoto; Atsushi Kawakami; Toshihisa Ogawa; Masaomi Nangaku; Taroh Iiri
Journal:  JCI Insight       Date:  2019-04-18

6.  Extra-long Gαs variant XLαs protein escapes activation-induced subcellular redistribution and is able to provide sustained signaling.

Authors:  Zun Liu; Serap Turan; Vanessa L Wehbi; Jean-Pierre Vilardaga; Murat Bastepe
Journal:  J Biol Chem       Date:  2011-09-02       Impact factor: 5.157

7.  Analysis of the V2 Vasopressin Receptor (V2R) Mutations Causing Partial Nephrogenic Diabetes Insipidus Highlights a Sustainable Signaling by a Non-peptide V2R Agonist.

Authors:  Noriko Makita; Tomohiko Sato; Yuki Yajima-Shoji; Junichiro Sato; Katsunori Manaka; Makiko Eda-Hashimoto; Masanori Ootaki; Naoki Matsumoto; Masaomi Nangaku; Taroh Iiri
Journal:  J Biol Chem       Date:  2016-09-06       Impact factor: 5.157

Review 8.  The GNAS complex locus and human diseases associated with loss-of-function mutations or epimutations within this imprinted gene.

Authors:  Serap Turan; Murat Bastepe
Journal:  Horm Res Paediatr       Date:  2013-10-03       Impact factor: 2.852

9.  Identification of a novel mutation in a pseudohypoparathyroidism family.

Authors:  Zhi-Min Miao; Can Wang; Bin-Bin Wang; Dong-Mei Meng; Dong-Mei Su; Zhi Cheng; Qiao-Lian Wen; Lin Han; Qing Yu; Xu Ma; Chang-Gui Li
Journal:  Int J Endocrinol       Date:  2011-07-21       Impact factor: 3.257

10.  A Novel T55A Variant of Gs α Associated with Impaired cAMP Production, Bone Fragility, and Osteolysis.

Authors:  Kelly Wentworth; Alyssa Hsing; Ashley Urrutia; Yan Zhu; Andrew E Horvai; Murat Bastepe; Edward C Hsiao
Journal:  Case Rep Endocrinol       Date:  2016-08-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.